.slides > li:first-child { display: block; } .image__fallback { width: 100vw; display: block !important; max-width: 100vw !important; margin-bottom: 0; } .image__fallback + .hsContainer__image { display: none !important; } .hsContainer { height: auto !important; } .no-js-only { display: inherit !important; } .icon-cart.cart-button { display: none; } .lazyload, .cart_page_image img { opacity: 1; -webkit-filter: blur(0); filter: blur(0); } .bcg .hsContent { background-color: transparent; } .animate_right, .animate_left, .animate_up, .animate_down { opacity: 1; } .flexslider .slides>li { display: block; } .product_section .product_form { opacity: 1; } .multi_select, form .select { display: block !important; } .swatch_options { display: none; }

Research lags in business ventures

November 11, 2015

From The Australian:

Imagine if universities had to compete with each other to get research work from businesses armed with their own government research grants? Stephen Tomisich, head of Melbourne-based medical technology company Trajan Scientific and Medical...

Read the full article at The Australian website: Research lags in business ventures

Stephen Tomisich, Director and Chief Executive Officer, Trajan Scientific and Medical

Also in News

Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Trajan Scientific and Medical to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.

October 10, 2022

Trajan Scientific and Medical, and the Baker Heart and Diabetes Institute, have reached an in-principle understanding for Trajan to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.